LAB - Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript
2024-05-11 12:45:27 ET
Standard BioTools Inc. (LAB)
Q1 2024 Earnings Conference Call
May 08, 2024, 4:30 PM ET
Company Participants
David Holmes - Investor Relations
Michael Egholm - President and Chief Executive Officer
Jeff Black - Chief Financial Officer
Adam Taich - Chief Strategy Officer
Conference Call Participants
Matthew Stanton - Jefferies
Daniel Brennan - TD Cowen
Paul Knight - KeyBanc Capital Markets
Presentation
Operator
Good day and welcome to the Standard BioTools Inc. First Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, today's event is being recorded.
It's now my pleasure to introduce David Holmes of Investor Relations.
David Holmes
Thank you, operator, and good afternoon, everyone. Welcome to Standard BioTools' first quarter 2024 earnings conference call. Leading the call today is Michael Egholm, President and Chief Executive Officer; and Jeff Black, Chief Financial Officer.
At the close of market today, Standard BioTools released its financial results for the quarter ended March 31, 2024. During the call, we will review our results and provide an update on our financial and operational performance, 2024 outlook, market trends and strategic initiatives.
During this call, we will be making forward-looking statements about events and circumstances that have not yet occurred, including plans, projections of our business, our outlook for 2024 and future financial results, market trends and opportunities, and our expectations related to the combined operations with SomaLogic, including potential synergies and our business outlook for the combined company....
Standard BioTools Inc. (LAB) Q1 2024 Earnings Call Transcript